GSK3B and schizophrenia: We did not find significant differences in mTOR, GSK3-α and GSK3-β expression between our chronic paranoid patient and control groups [25], and our results are consistent with those that found no differences in GSK3-α and GSK3-β levels in peripheral blood lymphocytes in chronic paranoid schizophrenia patients.